Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trial

scientific article published on 01 July 1999

Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID10439170

P2093author name stringS P Balcerzak
R B Livingston
H A Burris
D R Gandara
J J Crowley
D F Moore
P J Hesketh
H M Gross
S K Williamson
J W Goodwin
D Peereboom
P433issue4
P921main subjectdocetaxelQ420436
phase II clinical trialQ42824440
P304page(s)237-241
P577publication date1999-07-01
P1433published inThe Cancer Journal from Scientific AmericanQ27714220
P1476titleEvaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trial
P478volume5

Reverse relations

cites work (P2860)
Q46727425A phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancer
Q33929465Advanced non-small cell lung carcinoma: the emerging role of docetaxel
Q35569379Chemotherapy for small cell lung cancer: a comprehensive review
Q33817153Features of potentially predictive biomarkers of chemotherapeutic efficacy in small cell lung cancer
Q37957744Pharmacoethnicity of docetaxel-induced severe neutropenia: integrated analysis of published phase II and III trials.
Q37163139Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies
Q79236016Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study
Q36977870Platinum-based chemotherapy for variant castrate-resistant prostate cancer